Arancia, G.

ifn -β bxpc -3 cells expression effect cancer combination protein treatment activation activity p 27 expression phosphorylation *** control growth stat -3 increase pathway pancreatic vitale signi experiment type i ifns inhibition pancreatic cancer cells cycle signi ficantly analysis autophagy factor survival troglitazone eif 4e phosphorylation concentration tecnology inc ppar -γ antitumor activity kinase caraglia biotechnology transfection agent beclin 4 ° c apoptosi receptor error bars pancreatic cancer incubation interferon advance method §§§ speci methods ”. 169–184 mechanism complex ficantly stat -3 activation signal speci fic antibodies phase intensity 0.001 antibody agonist cancer cells growth inhibition probe deviation tumor result assay ficant ppar -γ agonists “ materials cell cycle modulation wt stat